[HTML][HTML] Targeting HER2 genomic alterations in non-small cell lung cancer

J Zeng, W Ma, RB Young, T Li - Journal of the National Cancer Center, 2021 - Elsevier
NSCLC tumors that contain an adenocarcinoma component, regardless of histologic grade,
dominant histologic subtype, clinical characteristics … common HER2 mutations in lung cancer

[HTML][HTML] Consensus for HER2 alterations testing in non-small-cell lung cancer

S Ren, J Wang, J Ying, T Mitsudomi, DH Lee, Z Wang… - ESMO open, 2022 - Elsevier
… that HER2 mutations predominantly occur in adenocarcinoma … specific genetic variants (eg
EGFR mutations), these features … It is appropriate to include ErbB2 (HER2) mutation analysis

Targeting HER2 alterations in non–small-cell lung cancer: a comprehensive review

J Zhao, Y Xia - JCO precision oncology, 2020 - ascopubs.org
… F, Barassi F, Fresu G, et al: Mutational analysis of the HER2 gene in lung tumorsCaucasian
patients: Mutations are mainly present in adenocarcinomas with bronchioloalveolar features

[HTML][HTML] Molecular epidemiology of the main druggable genetic alterations in non-small cell lung cancer

SS Fois, P Paliogiannis, A Zinellu, AG Fois… - International journal of …, 2021 - mdpi.com
… [7], probably due to changes in the characteristics of cigarettes … for patients with EGFR-mutated
lung adenocarcinoma, … mutation, and the diagnosis of the former bronchioalveolar

[HTML][HTML] Genomic profiling and prognostic value analysis of genetic alterations in Chinese resected lung cancer with invasive mucinous adenocarcinoma

L Cai, J Wang, J Yan, J Zeng, L Zhu, J Liang… - Frontiers in …, 2021 - frontiersin.org
… Given that each tumor sample had the corresponding white … in survival between patients
with EGFR-mutated tumors and … of the genomic characteristics of IMA patients in an East-Asian …

Non-amplification genetic alterations of HER2 gene in non-small cell lung carcinoma

A Mehta, S Nathany, R Tripathi, SK Sharma… - Journal of Clinical …, 2021 - jcp.bmj.com
… . Mutational analysis of the HER2 gene in lung tumors from Caucasian patients:
mutations are mainly present in adenocarcinomas with bronchioloalveolar features. Int J …

[HTML][HTML] Deciphering the Impact of HER2 Alterations on Non-Small-Cell Lung Cancer: From Biological Mechanisms to Therapeutic Approaches

C Bontoux, J Benzaquen, V Hofman, S Heeke… - Journal of Personalized …, 2022 - mdpi.com
… of the MSKCC 2020 lung adenocarcinoma cohort (available … aspects, HER2 mutations in
lung cancer are significantly … /HER2 inhibitor with a smaller size and flexible structure compared …

Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion

QS Chu - Therapeutic advances in medical oncology, 2020 - journals.sagepub.com
mutations in non-small cell lung cancer in Asian and White … on clinical characteristics of
BRAF-mutated NSCLC have … is found in 1–2% of lung adenocarcinoma and these patients are …

CHAPTER OUTLINE Introduction Pulmonary Adenocarcinoma Clinical and Prognostic Relevance of Adenocarcinoma Subtypes

M Cabanero, MDP Pal, MS Tsao - Lung Cancer E-Book: An …, 2023 - books.google.com
… harbored genetic alterations more characteristic of NSCLC (… More than 90% of RAS
mutations in lung cancers are foundmutation in lung adenocarcinomas with bronchioloalveolar

… molecular and clinicopathologic analysis of 200 pulmonary invasive mucinous adenocarcinomas identifies distinct characteristics of molecular subtypes

JC Chang, M Offin, C Falcon, D Brown… - Clinical Cancer …, 2021 - AACR
… known as mucinous bronchioloalveolar carcinoma, is a … The mean tumor mutation burden
(TMB) was 3.6 mutations per … To our knowledge, this is the third reported case of lung cancer